SPL Mapping FHIR R5 Implementation Guide
0.2.1 - Build CI
SPL Mapping FHIR R5 Implementation Guide
0.2.1 - Build CI
SPL Mapping FHIR R5 Implementation Guide, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.2.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-spl/ and changes regularly. See the Directory of published versions
| Page standards status: Trial-use | Maturity Level: 1 |
{
"resourceType" : "ValueSet",
"id" : "valueset-splMarketingCategories",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet valueset-splMarketingCategories</b></p><a name=\"valueset-splMarketingCategories\"> </a><a name=\"hcvalueset-splMarketingCategories\"> </a><a name=\"valueset-splMarketingCategories-en-US\"> </a><ul><li>Include these codes as defined in <a href=\"http://terminology.hl7.org/6.0.2/CodeSystem-v3-nciThesaurus.html\"><code>http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>C101533</td><td>UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE</td></tr><tr><td>C117717</td><td>Master File</td></tr><tr><td>C132333</td><td>Approved Drug Product Manufactured Under Contract</td></tr><tr><td>C132334</td><td>OTC Monograph Drug Product Manufactured Under Contract</td></tr><tr><td>C132335</td><td>Unapproved Drug Product Manufactured Under Contract</td></tr><tr><td>C175238</td><td>Multi-Market Approved Product</td></tr><tr><td>C175462</td><td>SIP Approved Drug</td></tr><tr><td>C181659</td><td>Outsourcing Facility Compounded Human Drug Product (Exempt From Approval Requirements)</td></tr><tr><td>C190698</td><td>Outsourcing Facility Compounded Human Drug Product (Not Marketed - Not Distributed)</td></tr><tr><td>C200263</td><td>OTC Monograph Drug</td></tr><tr><td>C73583</td><td>ANADA</td></tr><tr><td>C73584</td><td>ANDA</td></tr><tr><td>C73585</td><td>BLA</td></tr><tr><td>C73586</td><td>BULK ACTIVE INGREDIENT</td></tr><tr><td>C73587</td><td>BULK INACTIVE INGREDIENT</td></tr><tr><td>C73588</td><td>CONDITIONAL NADA</td></tr><tr><td>C73590</td><td>EXPORT ONLY</td></tr><tr><td>C73593</td><td>NADA</td></tr><tr><td>C73594</td><td>NDA</td></tr><tr><td>C73605</td><td>NDA AUTHORIZED GENERIC</td></tr><tr><td>C73613</td><td>UNAPPROVED MEDICAL GAS</td></tr><tr><td>C73614</td><td>UNAPPROVED HOMEOPATHIC</td></tr><tr><td>C73615</td><td>UNAPPROVED VITAMIN DRUG</td></tr><tr><td>C73626</td><td>BULK INGREDIENT</td></tr><tr><td>C73627</td><td>UNAPPROVED DRUG OTHER MARKETING CATEGORY</td></tr><tr><td>C75302</td><td>IND</td></tr><tr><td>C80438</td><td>EXEMPT DEVICE</td></tr><tr><td>C80440</td><td>HUMANITARIAN DEVICE EXEMPTION</td></tr><tr><td>C80441</td><td>PREMARKET APPLICATION</td></tr><tr><td>C80442</td><td>PREMARKET NOTIFICATION</td></tr><tr><td>C86952</td><td>DIETARY SUPPLEMENT</td></tr><tr><td>C86964</td><td>MEDICAL FOOD</td></tr><tr><td>C86965</td><td>COSMETIC</td></tr><tr><td>C92556</td><td>LEGALLY MARKETED UNAPPROVED NEW ANIMAL DRUGS FOR MINOR SPECIES</td></tr><tr><td>C94795</td><td>DRUG FOR FURTHER PROCESSING</td></tr><tr><td>C95600</td><td>APPROVED DRUG PRODUCT MANUFACTURED EXCLUSIVELY FOR PRIVATE LABEL DISTRIBUTOR</td></tr><tr><td>C95601</td><td>OTC MONOGRAPH DRUG PRODUCT MANUFACTURED EXCLUSIVELY FOR PRIVATE LABEL DISTRIBUTOR</td></tr><tr><td>C95602</td><td>UNAPPROVED DRUG PRODUCT MANUFACTURED EXCLUSIVELY FOR PRIVATE LABEL DISTRIBUTOR</td></tr><tr><td>C96793</td><td>BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING</td></tr><tr><td>C96794</td><td>BULK INGREDIENT FOR ANIMAL PRESCRIPTION COMPOUNDING</td></tr><tr><td>C96966</td><td>Emergency Use Authorization</td></tr><tr><td>C98252</td><td>BULK INGREDIENT FOR ANIMAL DRUG COMPOUNDING</td></tr></table></li></ul></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode" : "brr"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger" : 1,
"_valueInteger" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical" : "http://hl7.org/fhir/us/spl/ImplementationGuide/hl7.fhir.us.spl"
}
]
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode" : "trial-use",
"_valueCode" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical" : "http://hl7.org/fhir/us/spl/ImplementationGuide/hl7.fhir.us.spl"
}
]
}
}
],
"url" : "http://hl7.org/fhir/us/spl/ValueSet/valueset-splMarketingCategories",
"version" : "0.2.1",
"name" : "SPLMarketingCategories",
"title" : "SPL Marketing Categories",
"status" : "active",
"experimental" : false,
"date" : "2024-10-26T03:36:34+00:00",
"publisher" : "HL7 International / Biomedical Research and Regulation",
"contact" : [
{
"name" : "HL7 International / Biomedical Research and Regulation",
"telecom" : [
{
"system" : "url",
"value" : "http://www.hl7.org/Special/committees/rcrim"
}
]
}
],
"description" : "Codes from NCI Thesaurus for SPL Marketing Categories (C43164 Subset)",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US",
"display" : "United States of America"
}
]
}
],
"compose" : {
"include" : [
{
"system" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"concept" : [
{
"code" : "C101533",
"display" : "UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE"
},
{
"code" : "C117717",
"display" : "Master File"
},
{
"code" : "C132333",
"display" : "Approved Drug Product Manufactured Under Contract"
},
{
"code" : "C132334",
"display" : "OTC Monograph Drug Product Manufactured Under Contract"
},
{
"code" : "C132335",
"display" : "Unapproved Drug Product Manufactured Under Contract"
},
{
"code" : "C175238",
"display" : "Multi-Market Approved Product"
},
{
"code" : "C175462",
"display" : "SIP Approved Drug"
},
{
"code" : "C181659",
"display" : "Outsourcing Facility Compounded Human Drug Product (Exempt From Approval Requirements)"
},
{
"code" : "C190698",
"display" : "Outsourcing Facility Compounded Human Drug Product (Not Marketed - Not Distributed)"
},
{
"code" : "C200263",
"display" : "OTC Monograph Drug"
},
{
"code" : "C73583",
"display" : "ANADA"
},
{
"code" : "C73584",
"display" : "ANDA"
},
{
"code" : "C73585",
"display" : "BLA"
},
{
"code" : "C73586",
"display" : "BULK ACTIVE INGREDIENT"
},
{
"code" : "C73587",
"display" : "BULK INACTIVE INGREDIENT"
},
{
"code" : "C73588",
"display" : "CONDITIONAL NADA"
},
{
"code" : "C73590",
"display" : "EXPORT ONLY"
},
{
"code" : "C73593",
"display" : "NADA"
},
{
"code" : "C73594",
"display" : "NDA"
},
{
"code" : "C73605",
"display" : "NDA AUTHORIZED GENERIC"
},
{
"code" : "C73613",
"display" : "UNAPPROVED MEDICAL GAS"
},
{
"code" : "C73614",
"display" : "UNAPPROVED HOMEOPATHIC"
},
{
"code" : "C73615",
"display" : "UNAPPROVED VITAMIN DRUG"
},
{
"code" : "C73626",
"display" : "BULK INGREDIENT"
},
{
"code" : "C73627",
"display" : "UNAPPROVED DRUG OTHER MARKETING CATEGORY"
},
{
"code" : "C75302",
"display" : "IND"
},
{
"code" : "C80438",
"display" : "EXEMPT DEVICE"
},
{
"code" : "C80440",
"display" : "HUMANITARIAN DEVICE EXEMPTION"
},
{
"code" : "C80441",
"display" : "PREMARKET APPLICATION"
},
{
"code" : "C80442",
"display" : "PREMARKET NOTIFICATION"
},
{
"code" : "C86952",
"display" : "DIETARY SUPPLEMENT"
},
{
"code" : "C86964",
"display" : "MEDICAL FOOD"
},
{
"code" : "C86965",
"display" : "COSMETIC"
},
{
"code" : "C92556",
"display" : "LEGALLY MARKETED UNAPPROVED NEW ANIMAL DRUGS FOR MINOR SPECIES"
},
{
"code" : "C94795",
"display" : "DRUG FOR FURTHER PROCESSING"
},
{
"code" : "C95600",
"display" : "APPROVED DRUG PRODUCT MANUFACTURED EXCLUSIVELY FOR PRIVATE LABEL DISTRIBUTOR"
},
{
"code" : "C95601",
"display" : "OTC MONOGRAPH DRUG PRODUCT MANUFACTURED EXCLUSIVELY FOR PRIVATE LABEL DISTRIBUTOR"
},
{
"code" : "C95602",
"display" : "UNAPPROVED DRUG PRODUCT MANUFACTURED EXCLUSIVELY FOR PRIVATE LABEL DISTRIBUTOR"
},
{
"code" : "C96793",
"display" : "BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING"
},
{
"code" : "C96794",
"display" : "BULK INGREDIENT FOR ANIMAL PRESCRIPTION COMPOUNDING"
},
{
"code" : "C96966",
"display" : "Emergency Use Authorization"
},
{
"code" : "C98252",
"display" : "BULK INGREDIENT FOR ANIMAL DRUG COMPOUNDING"
}
]
}
]
}
}
IG © 2020+ HL7 International / Biomedical Research and Regulation. Package hl7.fhir.us.spl#0.2.1 based on FHIR 5.0.0. Generated 2024-10-26
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change